Janux Therapeutics Inc
JANX
$25.76+0.65 (+2.59%)
Aug 18, 2025, 3:37 PM
Financials
| 52Week High | 71.71 | 52Week Low | 21.97 |
| Beta | 2.88 | Current Ratio Annual | 60.82 |
| Current Ratio Quarterly | 47.03 | Market Cap | 1.50B |
| Net Profit Margin TTM | -463.91 | Operating Margin TTM | -658.76 |
| Price To Book | 1.52 | Price To Sales TTM | 115.32 |
| Quick Ratio Annual | 60.32 | Quick Ratio Quarterly | 46.85 |
| Return On Assets TTM | -11.01 | Return On Equity TTM | -11.48 |
| Return On Investment TTM | -11.48 | Revenue Growth3Y | 42.75 |
| Revenue Growth TTMYoy | -97.10 | Revenue Per Share TTM | 0.01 |
13F Aggregates
| Quarter | Funds | Added | Exited | Increased | Decreased | Unchanged | Shares | Value |
|---|---|---|---|---|---|---|---|---|
| Dec 31, 2024 | 219 | 1 | 1 | 8 | 2 | 0 | 65.20M | $3.33B |
| Mar 31, 2025 | 182(-17%) | 19(+1800%) | 55(+5400%) | 97(+1113%) | 42(+2000%) | 21(+%) | 67.26M(+3%) | $1.76B(-47%) |
| Jun 30, 2025 | 172(-5%) | 12(-37%) | 22(-60%) | 77(-21%) | 54(+29%) | 23(+10%) | 66.64M(-1%) | $1.49B(-16%) |